These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 7731693

  • 21. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [Abstract] [Full Text] [Related]

  • 22. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
    Sarkar AK, Nuchtern JG.
    Cancer Res; 2000 Apr 01; 60(7):1908-13. PubMed ID: 10766179
    [Abstract] [Full Text] [Related]

  • 23. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?
    Scott D, Elsden J, Pearson A, Lunec J.
    Cancer Lett; 2003 Jul 18; 197(1-2):81-6. PubMed ID: 12880964
    [Abstract] [Full Text] [Related]

  • 24. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
    Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ.
    Virology; 2004 Dec 20; 330(2):471-80. PubMed ID: 15567440
    [Abstract] [Full Text] [Related]

  • 25. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH.
    Pandita A, Godbout R, Zielenska M, Thorner P, Bayani J, Squire JA.
    Genes Chromosomes Cancer; 1997 Nov 20; 20(3):243-52. PubMed ID: 9365831
    [Abstract] [Full Text] [Related]

  • 26. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA, Lazarova DL, Ross RA, Biedler JL.
    Oncol Res; 1997 Nov 20; 9(9):467-76. PubMed ID: 9495452
    [Abstract] [Full Text] [Related]

  • 27. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D.
    Cancer Res; 1994 Aug 01; 54(15):4238-42. PubMed ID: 7518353
    [Abstract] [Full Text] [Related]

  • 28. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
    Narath R, Lörch T, Rudas M, Ambros PF.
    Cytometry B Clin Cytom; 2004 Jan 01; 57(1):15-22. PubMed ID: 14696059
    [Abstract] [Full Text] [Related]

  • 29. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma.
    Hiyama E, Hiyama K, Yokoyama T, Fukuba I, Yamaoka H, Shay JW, Matsuura Y.
    Clin Cancer Res; 1999 Mar 01; 5(3):601-9. PubMed ID: 10100712
    [Abstract] [Full Text] [Related]

  • 30. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
    Shohet JM, Hicks MJ, Plon SE, Burlingame SM, Stuart S, Chen SY, Brenner MK, Nuchtern JG.
    Cancer Res; 2002 Feb 15; 62(4):1123-8. PubMed ID: 11861392
    [Abstract] [Full Text] [Related]

  • 31. No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas.
    De Preter K, Speleman F, Combaret V, Lunec J, Board J, Pearson A, De Paepe A, Van Roy N, Laureys G, Vandesompele J.
    J Clin Oncol; 2005 May 01; 23(13):3167-8; author reply 3168-70. PubMed ID: 15860893
    [No Abstract] [Full Text] [Related]

  • 32. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.
    Cancer; 2004 Oct 15; 101(8):1873-81. PubMed ID: 15386308
    [Abstract] [Full Text] [Related]

  • 33. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.
    De Preter K, Speleman F, Combaret V, Lunec J, Laureys G, Eussen BH, Francotte N, Board J, Pearson AD, De Paepe A, Van Roy N, Vandesompele J.
    Mod Pathol; 2002 Feb 15; 15(2):159-66. PubMed ID: 11850545
    [Abstract] [Full Text] [Related]

  • 34. Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas.
    Schneider SS, Zehnbauer BA, Vogelstein B, Brodeur GM.
    Prog Clin Biol Res; 1991 Feb 15; 366():71-6. PubMed ID: 2068181
    [Abstract] [Full Text] [Related]

  • 35. Amplification of a DEAD box protein gene in retinoblastoma cell lines.
    Godbout R, Squire J.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7578-82. PubMed ID: 7689221
    [Abstract] [Full Text] [Related]

  • 36. Role of DEAD box 1 in retinoblastoma and neuroblastoma.
    Godbout R, Li L, Liu RZ, Roy K.
    Future Oncol; 2007 Oct 15; 3(5):575-87. PubMed ID: 17927523
    [Abstract] [Full Text] [Related]

  • 37. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
    Westermann F, Henrich KO, Wei JS, Lutz W, Fischer M, König R, Wiedemeyer R, Ehemann V, Brors B, Ernestus K, Leuschner I, Benner A, Khan J, Schwab M.
    Clin Cancer Res; 2007 Aug 15; 13(16):4695-703. PubMed ID: 17652624
    [Abstract] [Full Text] [Related]

  • 38. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S, Ohira M, Isogai E, Nakada K, Nakagawara A.
    Int J Oncol; 2004 Jun 15; 24(6):1457-66. PubMed ID: 15138588
    [Abstract] [Full Text] [Related]

  • 39. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P.
    Cancer; 2002 Feb 01; 94(3):854-61. PubMed ID: 11857322
    [Abstract] [Full Text] [Related]

  • 40. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma).
    Lorenzana AN, Zielenska M, Thorner P, Gerrie B, Weitzman S, Squire J.
    Pediatr Pathol Lab Med; 1997 Feb 01; 17(6):875-83. PubMed ID: 9353827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.